GUNNAR H. ANDERSON Jr., M.D.; THEODORE G. DALAKOS, M.D.; ALAN ELIAS, M.D.; NESTOR TOMYCZ, M.D.; DAVID H. P. STREETEN, M.B., D.Phil.
Thirty-four patients, most with a low-renin "essential" hypertension, and seven normal subjects were placed on diuretic therapy for 4 to 5 weeks. In the normal subjects, infusion of a highly specific, competitive angiotensin II analogue (1-sar-8-ala-angiotensin II, saralasin) did not significantly change recumbent blood pressure either before or after diuretic administration. In contrast, the hypertensive patients as a group had a low stimulated plasma renin activity before diuretic therapy and a rise in blood pressure during saralasin infusion. After therapy, the stimulated plasma renin activity was higher and saralasin produced a fall in blood pressure in some patients who were still hypertensive. The results suggest that short-term diuretic therapy, which is thought to act through its natriuretic effects, can convert some patients with essential hypertension, many with a low or a low-normal stimulated plasma renin activity, to individuals whose hypertension is supported by angiotensin II. The fall in blood pressure to saralasin infusion after diuretic therapy was directly proportional to the height to which diuretics elevated the stimulated plasma renin activity.
Learn more about subscription options.
Register Now for a free account.
ANDERSON GH, DALAKOS TG, ELIAS A, TOMYCZ N, STREETEN DHP. Diuretic Therapy and Response of Essential Hypertension to Saralasin. Ann Intern Med. 1977;87:183–187. doi: 10.7326/0003-4819-87-2-183
Download citation file:
Published: Ann Intern Med. 1977;87(2):183-187.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only